Ed S Krol (Ed Krol)

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Topics

Protein Protein

Gas Chromatography

Photodynamic Therapy

Top Venues

Molecular pharmaceutics

Rapid communications in mass spectrometry : RCM

Journal of the American Society for Mass Spectrometry

This page only lists publications with an associated author ORCID identifier.

Publications

Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics 20 (2) (2023)
Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics 20 (2) (2023)
Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics 20 (2) (2023)
Omozojie P Aigbogun, Christopher P Phenix, Ed S Krol, Eric W Price
The Chemistry of Creating Chemically Programmed Antibodies (cPAbs): Site-Specific Bioconjugation of Small Molecules. Molecular pharmaceutics (2023)
Chukwunonso K Nwabufo, Anas El-Aneed, Ed S Krol
Tandem mass spectrometric analysis of novel caffeine scaffold-based bifunctional compounds for Parkinson's disease. Rapid communications in mass spectrometry : RCM 33 (23) (2020)
Wei Jin, Randy W Purves, Ed S Krol, Ildiko Badea, Anas El-Aneed
Mass Spectrometric Detection and Characterization of Metabolites of Gemini Surfactants Used as Gene Delivery Vectors. Journal of the American Society for Mass Spectrometry 31 (2) (2020)
Ellen K Wasan, Jinying Zhao, Joshua Poteet, Munawar A Mohammed, Jaweria Syeda, Kevin Soulsbury, Jacqueline Cawthray, Amanda Bunyamin, Chi Zhang, Brian M Fahlman, Ed S Krol
Development of a UV-Stabilized Topical Formulation of Nifedipine for the Treatment of Raynaud Phenomenon and Chilblains. Pharmaceutics 11 (11) (2019)